Free Trial
NYSE:MD

Pediatrix Medical Group (MD) Stock Price, News & Analysis

Pediatrix Medical Group logo
$13.82 -0.10 (-0.72%)
As of 03:05 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pediatrix Medical Group Stock (NYSE:MD)

Key Stats

Today's Range
$13.53
$13.90
50-Day Range
$12.46
$17.24
52-Week Range
$6.62
$17.67
Volume
267,915 shs
Average Volume
813,866 shs
Market Capitalization
$1.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.08
Consensus Rating
Hold

Company Overview

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Remove Ads

Pediatrix Medical Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

MD MarketRank™: 

Pediatrix Medical Group scored higher than 27% of companies evaluated by MarketBeat, and ranked 861st out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 2 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pediatrix Medical Group has only been the subject of 3 research reports in the past 90 days.

  • Read more about Pediatrix Medical Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Pediatrix Medical Group are expected to decrease by -2.90% in the coming year, from $1.38 to $1.34 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pediatrix Medical Group is -11.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pediatrix Medical Group is -11.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Pediatrix Medical Group has a PEG Ratio of 1.74. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Pediatrix Medical Group has a P/B Ratio of 1.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Pediatrix Medical Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.27% of the float of Pediatrix Medical Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pediatrix Medical Group has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Pediatrix Medical Group has recently increased by 7.36%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pediatrix Medical Group does not currently pay a dividend.

  • Dividend Growth

    Pediatrix Medical Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.27% of the float of Pediatrix Medical Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Pediatrix Medical Group has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Pediatrix Medical Group has recently increased by 7.36%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Pediatrix Medical Group has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Pediatrix Medical Group this week, compared to 3 articles on an average week.
  • Search Interest

    8 people have searched for MD on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pediatrix Medical Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.20% of the stock of Pediatrix Medical Group is held by insiders.

  • Percentage Held by Institutions

    97.71% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pediatrix Medical Group's insider trading history.
Receive MD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter.

MD Stock News Headlines

Zacks Research Has Positive Estimate for MD FY2025 Earnings
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
Zacks Research Has Optimistic Outlook of MD Q1 Earnings
3 Reasons MD is Risky and 1 Stock to Buy Instead
See More Headlines

MD Stock Analysis - Frequently Asked Questions

Pediatrix Medical Group's stock was trading at $13.12 at the start of the year. Since then, MD stock has increased by 4.9% and is now trading at $13.7650.
View the best growth stocks for 2025 here
.

Pediatrix Medical Group, Inc. (NYSE:MD) released its earnings results on Thursday, February, 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive trailing twelve-month return on equity of 15.47%.

Top institutional shareholders of Pediatrix Medical Group include Vanguard Group Inc. (12.59%), Alliancebernstein L.P. (8.56%), Dimensional Fund Advisors LP (3.79%) and Pacer Advisors Inc. (3.15%). Insiders that own company stock include C Marc Richards, James D Swift, Mark S Ordan, Mary Ann E Moore, Laura A Linynsky and Shirley A Weis.
View institutional ownership trends
.

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pediatrix Medical Group investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
2/20/2025
Today
3/13/2025
Next Earnings (Estimated)
5/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Services
Current Symbol
NYSE:MD
Previous Symbol
NYSE:PDX
Employees
5,170
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$17.08
High Stock Price Target
$18.50
Low Stock Price Target
$15.00
Potential Upside/Downside
+24.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
9.97
P/E Growth
1.74
Net Income
$-60,410,000.00
Pretax Margin
-5.03%

Debt

Sales & Book Value

Annual Sales
$2.01 billion
Cash Flow
$2.80 per share
Price / Cash Flow
4.91
Book Value
$8.91 per share
Price / Book
1.54

Miscellaneous

Free Float
84,162,000
Market Cap
$1.18 billion
Optionable
Optionable
Beta
1.48

Social Links

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:MD) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners